Biohit Oyj - Class B

OHEL:BIOBV (Finland)   Class B
€ 2.00 (+0.76%) May 27
16.63
P/B:
3.19
Market Cap:
€ 30.27M ($ 32.87M)
Enterprise V:
€ 24.16M ($ 26.24M)
Volume:
15.83K
Avg Vol (2M):
9.22K
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Biohit Oyj ( ) from 1999 to May 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Biohit Oyj stock (OHEL:BIOBV) PE ratio as of May 27 2024 is 16.63. More Details

Biohit Oyj (OHEL:BIOBV) PE Ratio (TTM) Chart

To

Biohit Oyj (OHEL:BIOBV) PE Ratio (TTM) Historical Data

Total 1261
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Biohit Oyj PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-28 16.6 2024-03-19 16.0
2024-05-24 16.5 2024-03-18 16.1
2024-05-23 16.7 2024-03-15 16.3
2024-05-22 16.4 2024-03-14 16.2
2024-05-21 16.5 2024-03-13 16.3
2024-05-20 16.7 2024-03-12 16.0
2024-05-17 16.8 2024-03-11 16.0
2024-05-16 16.8 2024-03-08 16.0
2024-05-15 16.6 2024-03-07 16.1
2024-05-14 16.5 2024-03-06 16.0
2024-05-13 16.5 2024-03-05 16.0
2024-05-10 16.7 2024-03-04 15.9
2024-05-08 16.8 2024-03-01 16.0
2024-05-07 16.7 2024-02-29 16.1
2024-05-06 16.7 2024-02-28 16.2
2024-05-03 16.7 2024-02-27 16.1
2024-05-02 16.5 2024-02-26 16.3
2024-04-30 16.8 2024-02-23 16.3
2024-04-29 16.7 2024-02-22 16.0
2024-04-26 16.8 2024-02-21 16.2
2024-04-25 16.6 2024-02-20 16.1
2024-04-24 16.8 2024-02-19 16.3
2024-04-23 16.8 2024-02-16 16.3
2024-04-22 17.0 2024-02-15 16.7
2024-04-19 17.1 2024-02-14 16.8
2024-04-18 17.1 2024-02-13 15.8
2024-04-17 17.1 2024-02-12 15.7
2024-04-16 17.1 2024-02-09 15.7
2024-04-15 17.1 2024-02-08 15.5
2024-04-12 17.2 2024-02-07 15.5
2024-04-11 17.3 2024-02-06 15.8
2024-04-10 17.1 2024-02-05 16.0
2024-04-09 17.2 2024-02-02 16.1
2024-04-08 17.3 2024-02-01 15.9
2024-04-05 17.1 2024-01-31 16.1
2024-04-04 16.8 2024-01-30 15.8
2024-04-03 16.7 2024-01-29 15.7
2024-04-02 16.9 2024-01-26 15.9
2024-03-28 16.7 2024-01-25 15.8
2024-03-27 16.3 2024-01-24 15.5
2024-03-26 16.0 2024-01-23 15.7
2024-03-25 15.8 2024-01-22 15.8
2024-03-22 16.0 2024-01-19 15.5
2024-03-21 16.0 2024-01-18 15.5
2024-03-20 16.1 2024-01-17 15.5

Biohit Oyj (OHEL:BIOBV) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.